Medtronic, Inc.

Matthew J Hoffman

Hyun J Yoon

Jonathan D Edmonson

Todd Jon Sheldon

Wade M Demmer

James D Reinke

Paul R Solheim

Michael L Ellingson

Ben W Herberg

Robert A Betzold

Juliana E Pronovici

Mark K Erickson

Bo Zhang

Nicholas C Wine

Alison M Seacord

Michael D Eggen

Jerry D Reiland

Ryan D Wyszynski

Yanzhu Zhao

Srikara V Peelukhana

Matthew P Hanly

Wei Gan

Gary J Pauly

Melani G Sullivan

Wei Jiang

Evan S Johnson

Ben E Herberg

Matthew P Hanley

Hyan J Yoon

Systems, devices, and methods for performing respiratory-based cardiac remodeling pacing therapy are described in this disclosure. A patent's respiration may be monitored, and the lower pacing limit for the cardiac remodeling pacing and support pacing therapy delivered to a patient may be adjusted based on the monitored respiration to achieve or restore respiratory sinus arrhythmia.

Respiratory-based cardiac remodeling pacing therapy

Implantable medical systems enter an exposure mode of operation, either manually via a down linked programming instruction or by automatic detection by the implantable system of exposure to a magnetic disturbance. A controller then determines the appropriate exposure mode by considering various pieces of information including the device type including whether the device has defibrillation capability, pre-exposure mode of therapy including which chambers have been paced, and pre-exposure cardiac activity that is either intrinsic or paced rates. Additional considerations may include determining whether a sensed rate during the exposure mode is physiologic or artificially produced by the magnetic disturbance. When the sensed rate is physiologic, then the controller uses the sensed rate to trigger pacing and otherwise uses asynchronous pacing at a fixed rate.

Methods and implantable medical systems that implement exposure modes of therapy that allow for continued operation during exposure to a magnetic disturbance

Implantable medical devices automatically switch from a normal mode of operation to an exposure mode of operation and back to the normal mode of operation. The implantable medical devices may utilize hysteresis timers in order to determine if entry and/or exit criteria for the exposure mode are met. The implantable medical devices may utilize additional considerations for entry to the exposure mode such as a confirmation counter or a moving buffer of sensor values. The implantable medical devices may utilize additional considerations for exiting the exposure mode of operation and returning to the normal mode, such as total time in the exposure mode, patient position, and high voltage source charge time in the case of devices with defibrillation capabilities.

Methods and implantable medical devices for automatic entry to an exposure mode of operation upon exposure to a magnetic disturbance

Techniques are disclosed for using a rate of wireless telemetry of an implantable medical device (IMD) to estimate a remaining longevity of a power source of the IMD. For example, the IMD sets a timer indicative of a remaining power capacity of the power source until a recommended replacement time (RRT) threshold. The IMD determines a power consumption of the IMD due to telemetry and updates, based on the power consumption of the IMD due to telemetry, the timer indicative of the remaining power capacity of the power source. The IMD determines, based on expiration of the timer indicative of the remaining power capacity of the power source, that the power source has reached the RRT threshold. In some examples, the IMD may output, to an external device and for display to a user, an indication that the power source has reached the RRT threshold.

Power source longevity

Techniques for facilitating authorized telemetry with an implantable device are provided. In one embodiment, for example, a method includes comparing, by a first device having a processor, first electronic information with second electronic information. The first electronic information is indicative of a first motion of a second device external to a body in which the implantable device is located, and the second electronic information is indicative of a second motion of the implantable device. The method also includes determining whether a defined level of correlation exists between the first electronic information and the second electronic information, and initiating a telemetry session between the second device and the implantable device based on a determination that the defined level of correlation exists between the first electronic information and the second electronic information.

Systems, apparatus, methods and computer-readable storage media facilitating authorized telemetry with an implantable device

In some examples, this disclosure describes a method for identifying a position within a patient for a first implantable medical device (IMD) to be implanted to facilitate tissue conductive communication (TCC) between the first IMD and a second IMD implanted within the patient. In some examples, the method includes storing model data that associates patient parameter data and second IMD position data with first IMD positions based on TCC communication performance, receiving patient parameter data indicating one or more anatomical or physiological parameters of the patient, receiving second IMD position data, performing analysis by at least one of comparing the model data to the patient parameter data and the second IMD position data, performing real-time computer simulations, or a combination of comparing and performing simulations, and outputting to a user an indication of the position for the first IMD to be implanted within the patient based on the analysis.

Determining a position for an implantable medical device

Growing community of inventors

Saint Paul, MN, United States of America

Matthew J Hoffman